PTH ameliorates acidosis-induced adverse effects in skeletal growth centers: The PTH-IGF-I axis

Kidney International

Volumn 63, Issue 2, 2003, Pages 487-500

  Green, Jacob ^a   Goldberg, Ruth ^a   Maor, Gila ^a  

^a RAMBAM MEDICAL CENTER   (Israel)

Author keywords

Chronic metabolic acidosis; IGF I; Mandibular condyle; Protein kinase C; PTH; Skeletal growth center

Indexed keywords

CELL MARKER; COLLAGEN TYPE 2; FORMALDEHYDE; MESSENGER RNA; NEUTRALIZING ANTIBODY; PARAFFIN; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN KINASE C; PROTEIN KINASE C ACTIVATOR; PROTEIN KINASE C ALPHA; PROTEOGLYCAN; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ACIDITY; ANIMAL TISSUE; ARTICLE; BIOLOGICAL MODEL; BONE GROWTH; CARTILAGE; CARTILAGE CELL; CELL DIFFERENTIATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HORMONE ACTION; INCUBATION TIME; MANDIBLE CONDYLE; METABOLIC ACIDOSIS; MOUSE; NONHUMAN; ORGAN CULTURE; PH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN INTERACTION; SIGNAL TRANSDUCTION;

EID: 0037245504     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.2003.00773.x     Document Type: Article

References (39)

1. GREEN J, KLEEMAN CR: Role of bone in regulation of systemic acid-base balance. Kidney Int 39:9-26, 1991
2. CALDAS A, BROYER M, DECHAUX M, KLEINKNECHT C: Primary distal tubular acidosis in childhood: Clinical study and long term follow-up of 28 patients. J Pediatr 121:233-241, 1992
3. CHAN JCM: Renal tubular acidosis. J Pediatr 102:327-340, 1983
4. MCSHERRY E, MORRIS RC JR: Attainment and maintenance of normal stature with alkali therapy in infants and children with classic renal tubular acidosis. J Clin Invest 61:509-527, 1978
5. BUSHINSKY DA: The contribution of acidosis to renal osteodystrophy. Kidney Int 47:1816-1832, 1995
6. SEBASTIAN A, HARRIS ST, OTTAWAY JH, et al: Improved mineral balance and skeletal metabolism in post-menopausal women treated with potassium bicarbonate. N Engl J Med 330:1776-1781, 1994
7. BUSHINSKY DA: Net calcium efflux from live bone during chronic metabolic but not respiratory acidosis. Am J Physiol 256:F836-F842, 1989
8. BUSHINSKY DA: Stimulated osteoclastic and suppressed osteoblastic activity in metabolic but not respiratory acidosis. Am J Physiol 268:C80-C88, 1995
9. GREEN J, MAOR G: Effect of metabolic acidosis on the growth hormone/IGF-I endocrine axis in skeletal growth centers. Kidney Int 57:2258-2267, 2000
10. OHLSSON C, BENGTSSON BA, ISAKSSON OGP, et al: Growth hormone and bone. Endocr Rev 19:55-79, 1998
11. JOHANSSON AG, LINDH E, LJUNGHALL S: Insulin-like growth factor I stimulates bone turnover in osteoporosis. Lancet 339:1619-1622, 1992
12. GREEN H, MORIKAWA M, NIXON T: A dual effector theory of growth-hormone action. Differentiation 29:195-198, 1985
13. ABOU SAMRA AB, JUPPNER H, FREEMAN MW, et al: Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells. A single receptor stimulates intracellular accumulation of both cAMP and inositol triphosphates and increases intracellular free calcium. Proc Natl Acad Sci USA 89:2732-2736, 1992
14. JUPPNER H, SAMRA AB, FREEMAN M, et al: A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science 254:1024-1026, 1991
15. KARAPLIS AC, LUZ A, GLOWACKI J, et al: Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes Dev 8:277-289, 1994
16. HEFTI E, TRECHSEL U, BONJOUR JP, et al: Increase of whole body calcium and skeletal mass in normal and osteoporotic adult rats treated with parathyroid hormone. Clin Sci 62:389-396, 1982
17. GUNNESS-HEY M, HOCK JM: Increased tubular bone mass in rats treated with human synthetic parathyroid hormone. Metab Bone Dis. 5:177-181, 1984
18. REEVE J, WILLIAMS D, HESP R, et al: Anabolic effects of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis. Lancet 1:1035-1038, 1976
19. REEVE J, MEUNIER PJ, PARSONS JA, et al: Anabolic effect of human PTH on trabecular bone in involutional osteoporosis: a multicenter trial. BMJ 280:1340-1344, 1980
20. NEER RM, ARNAUD CD, ZANCHETTA JR, et al: Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 344:1434-1441, 2001
21. LANSKE B, KARAPLIS AC, LEE K, et al: PTH/PTHrP receptor in early development and Indian-Hedgehog-regulated bone growth. Science 273:663-666, 1996
22. VORTKAMP A, LEE K, LANSKE B, et al: Regulation of rate of cartilage differentiation by Indian-Hedgehog and PTH-related protein. Science 273:613-622, 1996
23. AMIZUKA N, HENDERSON JE, HOSHI K: Programmed cell death of chondrocytes and aberrant chondrogenesis in mice homozygous for parathyroid hormone-related peptide gene deletion. Endocrinology 137:5055-5067, 1996
24. SCIPANI E, KRUSE K, JUPPNER H: A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science 268:98-100, 1995
25. HARVEY AK, YU XP, FROLIK CA, CHANDRASEKHAR S: Parathyroid hormone-(1-34) enhances aggrecan synthesis via an insulin-like growth factor-I pathway. J Biol Chem 274:23249-23255, 1999
26. PFEILSCHIFTER J, LAUKHUF F, BECKMANN BM, et al: Parathyroid hormone increases the concentration of insulin-like growth factor-I-and transforming growth factor beta I in rat bone. J Clin Invest 96:767-774, 1995
27. MCCARTHY TL, CENTRELLA M, CANALIS E: Parathyroid hormone enhances the transcript and polypeptide levels of insulin-like growth factor I in osteoblast-enriched cultures from fetal rat bone. Endocrinology 124:1247-1253, 1989
28. MCCARTHY TL, CENTRELLA M, CANALIS E: Cyclic AMP induces insulin-like growth factor I synthesis in osteoblast-enriched cultures. J Biol Chem 265:15353-15356, 1990
29. MAOR G, SILBERMANN M, MARK K, et al: Insulin enhances the growth of cartilage in organ and tissue cultures of mouse neonatal mandibular condyle. Calcif Tissue Int 52:291-299, 1993
30. ZHEN X, WEI L, WU Q, et al: Mitogen-activated protein kinase p38 mediates regulation of chondrocyte differentiation by parathyroid hormone. J Biol Chem 276:4879-4885, 2001
31. SYLVIA VL, BOYAN BD, DEAN DD, SCHWARTZ Z: The membrane effects of 17beta-estradiol on chondrocyte phenotypic expression are mediated by activation of protein kinase C through phospholipase C and G-proteins. J Seroid Biochem Mol Biol 73:211-224, 2000
32. FUKAYAMA S, SCHIPANI E, JUPPNER H, et al: Role of protein kinase-A in homologous down-regulation of parathyroid hormone (PTH)/PTH-related peptide receptor messenger ribonucleic acid in human osteoblast-like SaOS-2 cells. Endocrinology 134:1851-1858, 1994
33. CANALIS E, MCCARTHY T, CENTRELLA M: Growth factors and the regulation of bone remodeling. J Clin Invest 81:277-281, 1988
34. STREWLER GJ: The physiology of parathyroid hormone-related protein. N Engl J Med 342:177-185, 2000
35. SUDA N, SHIBATA S, YAMAZAKI K, et al: Parathyroid hormone-related protein regulates proliferation of condylar hypertrophic chondrocytes. J Bone Miner Res 14:1838-1847, 1999
36. KRIEG RJ, SANTOS F, CHAN JCM: Growth hormone, insulin-like growth factor and the kidney. Kidney Int 48:321-336, 1995
37. IONESCU AM, SCHWARZ EM, VINSON C, et al: PTHrP modulates chondrocyte differentiation through AP-1 and CREB signaling. J Biol Chem 276:11639-11647, 2001
38. DEMPSTER DW, COSMAN P, PARISIEN M, SHEN V: Anabolic actions of parathyroid hormone on bone. Endo Rev 14:690-709, 1993
39. NISHIDA S, YAMAGUCHI A, TANIZAWA T, et al: Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow. Bone 15:717-723, 1994